New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth
Study shows a drug created by Binghamton researcher used to treat Duchenne Muscular dystrophy avoids suppressing bone- and cartilage-related proteins, biomarker changes recover after boys’ transition from corticosteroid